Assignee profile:

Gador S.A.

City:

Buenos Aires

Country:

Argentina

Published Applications:

8

Last publication date:

2010-08-05

Patent Grants:

6

Last grant date:

2012-12-25

Top Inventors for applications by Gador S.A.

These are the the leading inventors for applications assigned to Gador S.A.:

Recent patent applications by Gador S.A.

Gador S.A. based in Buenos Aires, AR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2010-08-05 ✅ Patent 8,338,619 granted on 2012-12-25
US20100197935A1
Chemistry; metallurgy

Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it

#2 | 2010-08-05 ✅ Patent 8,952,172 granted on 2015-02-10
US20100197931A1
Chemistry; metallurgy

Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it

#3 | 2009-10-01 ✅ Patent 8,853,187 granted on 2014-10-07
US20090247491A1
Human necessities

Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof

#4 | 2009-08-13 ✅ Patent 8,153,648 granted on 2012-04-10
US20090203724A1
Chemistry; metallurgy

Solid and crystalline dutasteride and processes for preparation thereof

#5 | 2009-07-14 ✅ Patent 7,560,490 granted on 2009-07-14
US10466897
-

Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof

#6 | 2009-06-18
US20090155358A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF SHORT-ACTING HYPNOTIC AGENTS IN MODIFIED-RELEASE FORMS AND THE PROCEDURES TO PREPARE THE MENTIONED FORMULATION

#7 | 2008-09-18 ✅ Patent 7,846,474 granted on 2010-12-07
US20080227756A1
Human necessities

Use of bisphosphonates for the treatment of osteogenesis imperfecta

#8 | 2008-04-17
US20080090784A1
Chemistry; metallurgy

CRYSTALLINE FORM OF THE ZOLEDRONIC ACID, A PROCESS TO OBTAIN IT AND THE PHARMACEUTICAL COMPOSITION COMPRISING IT

AssigneeID:

223345 ⎘